TrialPloS one2017

Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.

Susan P Buchbinder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.